Skip to main content

Table 1 Percentage weekly change in pain severity among patients with painful DPN or PHN receiving treatment with pregabalin or gabapentin

From: Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting

  Pregabalin n = 141 Gabapentin n = 193
Mean dose mg/day 457 2400
Mean total weekly reduction versus baseline in daily pain scores %
Week 1 13.7 17.2
Week 2 23.2 25.1
Week 3 29.9 29.7
Week 4 39.1 32.1
Week 5 44.4 33.7
Week 6 44.2 34.9
Week 7 45.0 35.8
Week 8 46.3 36.4
Week 9 49.8 36.9
Week 10 51.1 37.2
Week 11 53.3 37.4
Week 12 54.1 37.6
  1. Data obtained from Protocol 1008–155 for pregabalin [7], and Protocols 945–210 and 945–211 for gabapentin [9, 10].